FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4309444829> ?p ?o ?g. }

• W4309444829 abstract "The efficacy of non-carbapenems as an empirical antibiotic for extended-spectrum β-lactamases (ESBL)-producing Escherichia coli and Klebsiella pneumoniae bacteremia in children remains controversial. We compared clinical and microbial outcomes according to the types of empirical antibiotics for treating pediatric patients with ESBL-producing E. coli and K. pneumoniae bacteremia.Data from pediatric patients aged ≤ 18 years who were hospitalized with monomicrobial ESBL-producing E. coli or K. pneumoniae bacteremia at Asan Medical Center Children's Hospital, Seoul, Korea between January 2014 and May 2019 were analyzed retrospectively. The impact of empirical therapy was assessed as 30-day all-cause mortality and 2-day microbiological outcomes evaluated by the sterility of blood cultures collected on day 2 after empirical antibiotic administration. Logistic regression analysis was used to control for the effects of confounding variables.A total of 53 patients with bacteremia caused by ESBL-producing E. coli (n = 29) and K. pneumoniae (n = 24) were included in this study; the median age was 3.6 years, and all had underlying comorbidities. As empirical antibiotics, 27 patients were treated with meropenem, and non-carbapenem agents were administered to 26 patients; 84.6% (22/26) were converted to carbapenem antibiotics as the definitive antibiotic by day 2 after empirical antibiotic administration. Overall, the 30-day all-cause mortality of ESBL-producing E. coli and K. pneumoniae bacteremia was 17.0% (9/53). After adjustment, there was no statistically significant association of use of a non-carbapenem agent as an empirical antibiotic with microbiological failure on day 2 and 30-day all-cause mortality [adjusted odds ratio (OR) 1.0; 95% confidence interval (CI) 0.22-4.88, and adjusted OR 0.1; 95% CI 0.01-1.56].The empirical use of non-carbapenems might not be a risk factor for mortality and early microbiological outcomes in pediatric patients with ESBL-producing E. coli and K. pneumoniae BSI if early transition to appropriate antimicrobial therapy was possible." @default.
• W4309444829 created "2022-11-27" @default.
• W4309444829 creator A5047241783 @default.
• W4309444829 creator A5065909919 @default.
• W4309444829 creator A5069798213 @default.
• W4309444829 creator A5088116135 @default.
• W4309444829 date "2022-11-21" @default.
• W4309444829 modified "2023-10-09" @default.
• W4309444829 title "Initial empirical antibiotics of non-carbapenems for ESBL-producing E. coli and K. pneumoniae bacteremia in children: a retrospective medical record review" @default.
• W4309444829 cites W1989472454 @default.
• W4309444829 cites W1990247558 @default.
• W4309444829 cites W1993808329 @default.
• W4309444829 cites W1996500905 @default.
• W4309444829 cites W2011060414 @default.
• W4309444829 cites W2025355667 @default.
• W4309444829 cites W2030945745 @default.
• W4309444829 cites W2030970655 @default.
• W4309444829 cites W2031056779 @default.
• W4309444829 cites W2053104750 @default.
• W4309444829 cites W2091911714 @default.
• W4309444829 cites W2092279762 @default.
• W4309444829 cites W2092382060 @default.
• W4309444829 cites W2094718844 @default.
• W4309444829 cites W2107810227 @default.
• W4309444829 cites W2111368630 @default.
• W4309444829 cites W2119751940 @default.
• W4309444829 cites W2124795881 @default.
• W4309444829 cites W2124945254 @default.
• W4309444829 cites W2128199799 @default.
• W4309444829 cites W2142343447 @default.
• W4309444829 cites W2144582134 @default.
• W4309444829 cites W2151545489 @default.
• W4309444829 cites W2158873221 @default.
• W4309444829 cites W2159585072 @default.
• W4309444829 cites W2164916536 @default.
• W4309444829 cites W2166356134 @default.
• W4309444829 cites W2233620613 @default.
• W4309444829 cites W2255150230 @default.
• W4309444829 cites W2284486508 @default.
• W4309444829 cites W2473016454 @default.
• W4309444829 cites W2584483569 @default.
• W4309444829 cites W2884084741 @default.
• W4309444829 cites W2886232746 @default.
• W4309444829 cites W2892368225 @default.
• W4309444829 cites W2936006447 @default.
• W4309444829 cites W3094765036 @default.
• W4309444829 cites W3127699880 @default.
• W4309444829 cites W3196526648 @default.
• W4309444829 cites W3197070391 @default.
• W4309444829 doi "https://doi.org/10.1186/s12879-022-07881-7" @default.
• W4309444829 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/36404302" @default.
• W4309444829 hasPublicationYear "2022" @default.
• W4309444829 type Work @default.
• W4309444829 citedByCount "2" @default.
• W4309444829 countsByYear W43094448292023 @default.
• W4309444829 crossrefType "journal-article" @default.
• W4309444829 hasAuthorship W4309444829A5047241783 @default.
• W4309444829 hasAuthorship W4309444829A5065909919 @default.
• W4309444829 hasAuthorship W4309444829A5069798213 @default.
• W4309444829 hasAuthorship W4309444829A5088116135 @default.
• W4309444829 hasBestOaLocation W43094448291 @default.
• W4309444829 hasConcept C104317684 @default.
• W4309444829 hasConcept C126322002 @default.
• W4309444829 hasConcept C167135981 @default.
• W4309444829 hasConcept C177713679 @default.
• W4309444829 hasConcept C190139176 @default.
• W4309444829 hasConcept C203014093 @default.
• W4309444829 hasConcept C2776685102 @default.
• W4309444829 hasConcept C2777058267 @default.
• W4309444829 hasConcept C2779375183 @default.
• W4309444829 hasConcept C2779443120 @default.
• W4309444829 hasConcept C501593827 @default.
• W4309444829 hasConcept C547475151 @default.
• W4309444829 hasConcept C55493867 @default.
• W4309444829 hasConcept C71924100 @default.
• W4309444829 hasConcept C86803240 @default.
• W4309444829 hasConcept C89423630 @default.
• W4309444829 hasConcept C94665300 @default.
• W4309444829 hasConceptScore W4309444829C104317684 @default.
• W4309444829 hasConceptScore W4309444829C126322002 @default.
• W4309444829 hasConceptScore W4309444829C167135981 @default.
• W4309444829 hasConceptScore W4309444829C177713679 @default.
• W4309444829 hasConceptScore W4309444829C190139176 @default.
• W4309444829 hasConceptScore W4309444829C203014093 @default.
• W4309444829 hasConceptScore W4309444829C2776685102 @default.
• W4309444829 hasConceptScore W4309444829C2777058267 @default.
• W4309444829 hasConceptScore W4309444829C2779375183 @default.
• W4309444829 hasConceptScore W4309444829C2779443120 @default.
• W4309444829 hasConceptScore W4309444829C501593827 @default.
• W4309444829 hasConceptScore W4309444829C547475151 @default.
• W4309444829 hasConceptScore W4309444829C55493867 @default.
• W4309444829 hasConceptScore W4309444829C71924100 @default.
• W4309444829 hasConceptScore W4309444829C86803240 @default.
• W4309444829 hasConceptScore W4309444829C89423630 @default.
• W4309444829 hasConceptScore W4309444829C94665300 @default.
• W4309444829 hasIssue "1" @default.
• W4309444829 hasLocation W43094448291 @default.
• W4309444829 hasLocation W43094448292 @default.
• W4309444829 hasLocation W43094448293 @default.
• W4309444829 hasOpenAccess W4309444829 @default.

• next